EUVIMEDEUVIMED entdecken
Studienprotokoll

Modified G‐CSF/ATG‐Based Haploidentical Transplantation Protocol in Pediatric Primary Hemophagocytic Lymphohistiocytosis: A Long‐Term Follow‐Up Single‐Center Experience

Juan Xiao, Xingcheng Yang iD, Nanhai Wu, Shifen Fan, Zhouyang Liu, Fan Jiang iD, Jiao Chen, Jia Wei, Yuan Sun

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31495 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Juan Xiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Beijing Jingdu Children's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Granulocyte Colony-Stimulating Factor, Transplantation, Haploidentical, Antilymphocyte Serum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome caused by immune dysregulation. Hematopoietic stem cell transplantation (HSCT) represents the only option for long‐term cure for primary HLH. However, only around 25% of patients have a fully HLA‐matched donor.

Methods

In this retrospective study, we analyzed 42 pediatric patients with primary HLH who underwent haplo‐SCT using the modified granulocyte colony‐stimulating factor (G‐CSF)/antithymocyte globulin (ATG)‐based protocol. The conditioning regimen included 300–600 mg/m 2 etoposide (VP16), along with low doses of busulfan (Bu) (0.8–1.2 mg/kg every 6 hours on Days −8 to −6), cyclophosphamide (Cy) (10 mg/kg/day on Days −4 to −3), fludarabine (Flu) (30 mg/m 2 /day on Days −5 to −3), and ATG (8–9 mg/kg total dose on Days −5 to −2) to reduce complications.

Results

All 42 patients achieved successful engraftment. Following a median follow‐up period of 48.7 months, 32 of the 42 patients remained alive and disease free. The 2‐year overall survival (OS) rate was 78.4%, and the 5‐year OS rate was 73.7%. The 2‐year failure‐free survival (FFS) rate was 71.3%, and the 5‐year FFS rate was 66.5%. Patients who achieved complete remission at the time of HSCT showed better OS ( p < 0.05). The incidence of Grade III–IV acute graft‐versus‐host disease (GVHD) was 26.2%, and severe chronic GVHD was observed in 11.9% of patients. Thrombotic microangiopathy occurred in 13 patients, and veno‐occlusive disease in two patients.

Conclusions

This modified G‐CSF/ATG‐based haploidentical protocol demonstrates significant potential for pediatric patients with primary HLH, exhibiting commendable effectiveness and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticGranulocyte Colony-Stimulating FactorTransplantation, HaploidenticalAntilymphocyte SerumHematopoietic Stem Cell TransplantationTransplantation ConditioningHumansMaleFemaleChildChild, PreschoolRetrospective StudiesInfantFollow-Up StudiesAdolescentSurvival RateGraft vs Host DiseasePrognosisEtoposide

Stichwörter der Autor:innen

GVHD prophylaxisG‐CSF/ATG‐based protocolhaploidentical hematopoietic stem cell transplanthemophagocytic lymphohistiocytosisveno‐occlusive disease

Substanzen

Granulocyte Colony-Stimulating FactorAntilymphocyte SerumEtoposide

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Beijing Jingdu Children's Hospital, Beijing, China.
  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Xingcheng Yang, Fan Jiang

Zitieren

APA

Xiao, J., Yang, X., Wu, N., Fan, S., Liu, Z., Jiang, F., Chen, J., Wei, J., & Sun, Y. (2025). Modified G‐CSF/ATG‐Based Haploidentical Transplantation Protocol in Pediatric Primary Hemophagocytic Lymphohistiocytosis: A Long‐Term Follow‐Up Single‐Center Experience. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31495

Vancouver

Xiao J, Yang X, Wu N, Fan S, Liu Z, Jiang F, et al. Modified G‐CSF/ATG‐Based Haploidentical Transplantation Protocol in Pediatric Primary Hemophagocytic Lymphohistiocytosis: A Long‐Term Follow‐Up Single‐Center Experience. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31495

BibTeX
@article{Xiao2025,
  author = {Xiao, Juan and Yang, Xingcheng and Wu, Nanhai and Fan, Shifen and Liu, Zhouyang and Jiang, Fan and Chen, Jiao and Wei, Jia and Sun, Yuan},
  title = {Modified G‐CSF/ATG‐Based Haploidentical Transplantation Protocol in Pediatric Primary Hemophagocytic Lymphohistiocytosis: A Long‐Term Follow‐Up Single‐Center Experience},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31495}
}
Kostenlos starten →